Relapsed/Refractory B-Cell LymphomaPhase 1/2NCT03223610Papers
ViPOR Combination
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
What the film says
For high-risk acute myeloid leukemia, a bone marrow transplant is often the best chance, and a parent is usually a half-matched donor. Relapse afterward is the main way it fails.
The idea: give the new immune system a head start with trained natural killer cells from the same donor.
At Washington University in St. Louis, the donor's graft is first stripped of the T cells most likely to cause graft-versus-host disease. A week after transplant, the patient receives natural killer cells from that donor that were briefly exposed to three immune signals in the lab, which gives them a memory-like state: stronger, longer-lasting killers of leukemia. Low-dose interleukin-2 follows.
ABCD-NK is a pilot safety study led by Thomas Pfeiffer. Public record; not medical advice.
Sources behind this film
High-risk AML; transplant; haploidentical (parent) donor; relapse main failure; TCRαβ / CD19-depleted graft; ML NK cells infused day +7, followed by IL-2 subcutaneously; Cytokine (IL-12/15/18) pre-activation → memory-like NK (+1 more lines)
The drug
The HPC product obtained from a haploidentical donor will undergo ex vivo TCR alpha beta and CD19+ depletion, and will be infused fresh on Day 0. There is no maximum limit for CD34+ dose. A maximum dose of 1 x 10^5/kg recipient weight of TCRαβ cells should not be exceeded in the final HPC product.
The ML NK cells (dose: max capped at 20 x 10^6/kg recipient weight, minimum dose allowed is 0.5 x 10^6/kg recipient weight) will be infused on Day +7.
The study
This trial represents a single institution phase I/II pilot study with the primary objective of establishing the safety and feasibility of generating and infusing ML NK cells after TCRαβ haplo-HCT.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.